Jacob T. Borodovsky

Jacob T. Borodovsky

Auto-generated profile, based on publicly available information

Jacob T. Borodovsky

Geisel School of Medicine at Dartmouth

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2016 in International Journal of Drug Policy
Verified
Journal Article
Closed access
JBJacob T. Borodovsky
Jacob T. Borodovsky
BCBenjamin S. Crosier
Benjamin S. Crosier
DLDustin C. Lee
Dustin C. Lee
JSJames D. Sargent
James D. Sargent
ABAlan J. Budney
Alan J. Budney

1 April 2019 in Journal of Adolescent Health
Verified
Journal Article
Closed access
AKAshley A. Knapp
Ashley A. Knapp
DLDustin C. Lee
Dustin C. Lee
JBJacob T. Borodovsky
Jacob T. Borodovsky
SASamantha G. Auty
Samantha G. Auty
JGJoy Gabrielli
Joy Gabrielli
ABAlan J Budney
Alan J Budney

1 August 2017 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
JBJacob T. Borodovsky
Jacob T. Borodovsky
DLDustin C. Lee
Dustin C. Lee
BCBenjamin S. Crosier
Benjamin S. Crosier
JGJoy L. Gabrielli
Joy L. Gabrielli
JSJames D. Sargent
James D. Sargent
ABAlan J. Budney
Alan J. Budney

1 February 2016 in Drug and Alcohol Dependence
Verified
Journal Article
Closed access
DLDustin C. Lee
Dustin C. Lee
BCBenjamin S. Crosier
Benjamin S. Crosier
JBJacob T. Borodovsky
Jacob T. Borodovsky
JSJames D. Sargent
James D. Sargent
ABAlan J. Budney
Alan J. Budney

1 September 2014 in Journal of Substance Abuse Treatment
Verified
Journal Article
Closed access
ZSZev Schuman-Olivier
Zev Schuman-Olivier
RWRoger D. Weiss
Roger D. Weiss
BHBettina B. Hoeppner
Bettina B. Hoeppner
JBJacob Borodovsky
Jacob Borodovsky
MAMark J. Albanese
Mark J. Albanese

12 March 2019 in JMIR Mental Health
Verified
Journal Article
Open access
JSJackson M Steinkamp
Jackson M Steinkamp
NGNathaniel Goldblatt
Nathaniel Goldblatt
JBJacob T Borodovsky
Jacob T Borodovsky
ALAmy LaVertu
Amy LaVertu
IKIan M. Kronish
Ian M. Kronish
ZSZev Schuman-Olivier
Zev Schuman-Olivier
Background: Medication adherence is critical to the effectiveness of psychopharmacologic therapy. Psychiatric disorders present special adherence considerations, notably an altered capacity for decision making and the increased street value of controlled substances. A wide range of interventions designed to improve adherence in mental health and substance use disorders have been studied; recently, many have incorporated information technology (eg, mobile phone apps, electronic pill dispensers, and telehealth). Many intervention components have been studied across different disorders. Furthermore, many interventions incorporate multiple components, making it difficult to evaluate the effect of individual components in isolation. Objective: The aim of this study was to conduct a systematic scoping review to develop a literature-driven, transdiagnostic taxonomic framework of technology-based medication adherence intervention and measurement components used in mental health and substance use disorders. Methods: This review was conducted based on a published protocol (PROSPERO: CRD42018067902) in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses systematic review guidelines. We searched 7 electronic databases: MEDLINE, EMBASE, PsycINFO, the Cochrane Central Register of Controlled Trials, Web of Science, Engineering Village, and ClinicalTrials.gov from January 2000 to September 2018. Overall, 2 reviewers independently conducted title and abstract screens, full-text screens, and data extraction. We included all studies that evaluate populations or individuals with a mental health or substance use disorder and contain at least 1 technology-delivered component (eg, website, mobile phone app, biosensor, or algorithm) designed to improve medication adherence or the measurement thereof. Given the wide variety of studied interventions, populations, and outcomes, we did not conduct a risk of bias assessment or quantitative meta-analysis. We developed a taxonomic framework for intervention classification and applied it to multicomponent interventions across mental health disorders. Results: The initial search identified 21,749 results; after screening, 127 included studies remained (Cohen kappa: 0.8, 95% CI 0.72-0.87). Major intervention component categories include reminders, support messages, social support engagement, care team contact capabilities, data feedback, psychoeducation, adherence-based psychotherapy, remote care delivery, secure medication storage, and contingency management. Adherence measurement components include self-reports, remote direct visualization, fully automated computer vision algorithms, biosensors, smart pill bottles, ingestible sensors, pill counts, and utilization measures. Intervention modalities include short messaging service, mobile phone apps, websites, and interactive voice response. We provide graphical representations of intervention component categories and an element-wise breakdown of multicomponent interventions. Conclusions: Many technology-based medication adherence and monitoring interventions have been studied across psychiatric disease contexts. Interventions that are useful in one psychiatric disorder may be useful in other disorders, and further research is necessary to elucidate the specific effects of individual intervention components. Our framework is directly developed from the substance use disorder and mental health treatment literature and allows for transdiagnostic comparisons and an organized conceptual mapping of interventions.